T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Berkshire Hathaway Class A
BRK.A
$1.09T
| $11.4M | ﹤0.01% |
18
| – | – |
|
1077
BorgWarner
BWA
$13.8B
| $11.4M | ﹤0.01% |
328,572
-20,260
| -6% | -$663K |
|
1078
GitLab
GTLB
$7.32B
| $11.3M | ﹤0.01% |
194,417
+126,917
| +188% | +$8.32M |
|
1079
SAP
SAP
$242B
| $11.3M | ﹤0.01% |
57,751
+1,807
| +3% | +$321K |
|
1080
Pinnacle West Capital
PNW
$12.2B
| $11.2M | ﹤0.01% |
150,298
+2,892
| +2% | +$204K |
|
1081
Novartis
NVS
$288B
| $11.2M | ﹤0.01% |
115,849
+3,696
| +3% | +$379K |
|
1082
Etsy
ETSY
$7.4B
| $11.2M | ﹤0.01% |
163,037
-3,331
| -2% | -$239K |
|
1083
Mueller Water Products
MWA
$3.98B
| $11.2M | ﹤0.01% |
694,469
+83,567
| +14% | +$1.24M |
|
1084
Diageo
DEO
$52.8B
| $11M | ﹤0.01% |
73,870
+1,454
| +2% | +$213K |
|
1085
PBF Energy
PBF
$8.81B
| $10.9M | ﹤0.01% |
189,462
+11,683
| +7% | +$572K |
|
1086
UFP Technologies
UFPT
$2.48B
| $10.9M | ﹤0.01% |
43,134
+41,360
| +2,331% | +$7.86M |
|
1087
ING
ING
$102B
| $10.6M | ﹤0.01% |
642,621
+21,263
| +3% | +$304K |
|
1088
Okta
OKTA
$26.9B
| $10.6M | ﹤0.01% |
101,079
+4,823
| +5% | +$445K |
|
1089
Acadia Healthcare
ACHC
$2.82B
| $10.5M | ﹤0.01% |
133,093
+2,584
| +2% | +$211K |
|
1090
Essent Group
ESNT
$6.23B
| $10.5M | ﹤0.01% |
177,127
+49,393
| +39% | +$2.68M |
|
1091
AGCO
AGCO
$6.96B
| $10.5M | ﹤0.01% |
85,658
+50,892
| +146% | +$5.93M |
|
|
MASI
1092
DELISTED
Masimo
MASI
| $10.5M | ﹤0.01% |
71,548
-338,960
| -83% | -$43.8M |
|
1093
Fox Class A
FOXA
$27.5B
| $10.5M | ﹤0.01% |
335,482
-4,671
| -1% | -$142K |
|
1094
Cabaletta Bio
CABA
$442M
| $10.4M | ﹤0.01% |
612,398
+84,633
| +16% | +$1.82M |
|
1095
Neumora Therapeutics
NMRA
$321M
| $10.4M | ﹤0.01% |
+752,924
| New | +$12.2M |
|
1096
Hasbro
HAS
$13.6B
| $10.2M | ﹤0.01% |
181,123
+3,656
| +2% | +$186K |
|
1097
Agilon Health
AGL
$1.49B
| $10.2M | ﹤0.01% |
66,630
-338,965
| -84% | -$56.4M |
|
1098
Badger Meter
BMI
$3.78B
| $10.2M | ﹤0.01% |
62,769
+1,102
| +2% | +$169K |
|
1099
NeoGenomics
NEO
$2.11B
| $10.1M | ﹤0.01% |
645,492
+4,528
| +0.7% | +$69.9K |
|
1100
PennyMac Financial
PFSI
$4.13B
| $10.1M | ﹤0.01% |
110,962
-11,215
| -9% | -$980K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.